Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Socazolimab plus chemotherapy in extensive-stage small-cell lung cancer
NCT04878016Phase 3Completed
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Jul 2021
- Primary completion
- Oct 2023
- Modality
- Immune Checkpoint Inhibitors
- Countries
- 1
01
Overview
A Phase 3 trial of socazolimab in small cell lung cancer (SCLC), sponsored by Lee's Pharmaceutical Holdings Limited. Started Jul 2021; status: completed.
02
Drugs
socazolimab
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT04878016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04878016.